Rise Therapeutics Llc
Clinical trials sponsored by Rise Therapeutics Llc, explained in plain language.
-
Could a gut bacteria pill help ARDS patients breathe easier?
Disease control Not yet recruitingThis early-stage trial tests R-3750, a live biotherapeutic product, in 20 adults with late-stage acute respiratory distress syndrome (ARDS). The main goal is to see if it is safe and tolerable, while also checking for signs of improved lung function and less need for a ventilator…
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Probiotic pill could ease Sjogren's symptoms
Disease control Not yet recruitingThis early-stage study tests whether a probiotic taken by mouth (R-2487) is safe for people with Sjogren's Syndrome, an autoimmune disease causing dry eyes and mouth. About 36 adults will take the probiotic, and doctors will monitor side effects and check for changes in disease a…
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Probiotic pill could tame COPD Flare-Ups, early trial hopes
Disease control Not yet recruitingThis early-stage trial tests an oral probiotic called R-3750 in 27 people with mild-to-moderate COPD. The main goal is to see if it is safe and tolerable. Researchers will also check if it improves breathing and quality of life using a standard questionnaire. The study is not yet…
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC